IVA vs NBTX
Inventiva S.a. and Nanobiotix S.a., side by side — 7 fiscal years reported in EUR, drawn from SEC filings.
Most recent reported year
| Metric | IVA | NBTX |
|---|---|---|
| Revenue | €9.2M | €32.6M |
| Net income | €-184.2M | €-24.0M |
| Gross margin | · | · |
| Net margin | · | −73.5% |
| Return on equity | · | · |
| Diluted EPS | −€3.08 | −€0.50 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | · | €-34.0M |
| Equity | · | · |
| Net debt / equity | · | · |
| Current ratio | 0.92× | 1.09× |
| Revenue CAGR 5y | 5.6% | 67.0% |
| Profit CAGR 5y | · | · |
NBTX bills 3.5× the revenue of IVA, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
7 years side by side
| Fiscal year | IVA | NBTX |
|---|---|---|
| FY2024 | €9.2M | €-7.2M |
| FY2023 | €17.5M | €36.2M |
| FY2022 | €12.2M | €4.8M |
| FY2021 | €4.2M | €2.6M |
| FY2020 | €372,000 | €2.5M |
| FY2019 | €7.0M | €2.5M |
| FY2018 | €3.2M | €3.5M |
Bottom line
| Fiscal year | IVA | NBTX |
|---|---|---|
| FY2024 | €-184.2M | €-68.1M |
| FY2023 | €-110.4M | €-39.7M |
| FY2022 | €-54.3M | €-57.0M |
| FY2021 | €-49.6M | €-47.1M |
| FY2020 | €-33.6M | €-33.6M |
| FY2019 | €-30.2M | €-50.9M |
| FY2018 | €-33.0M | €-30.3M |
7 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2024 | +€16,389,000 | IVA |
| FY2023 | −€18,730,000 | NBTX |
| FY2022 | +€7,403,000 | IVA |
| FY2021 | +€1,547,000 | IVA |
| FY2020 | −€2,140,000 | NBTX |
| FY2019 | +€4,457,000 | IVA |
| FY2018 | −€282,000 | NBTX |
The higher-revenue side has changed between IVA and NBTX over this period. The gap has widened since the earliest year compared.
7 of 8 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
NBTX's net margin has been more volatile than IVA's over the 3 comparable fiscal years — 454.5 percentage points of standard deviation against 244.9.
3 of 7 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between IVA and NBTX over these 3 fiscal years — IVA led in 1 and NBTX in 2.
3 of 7 comparable fiscal years — a year missing data on either side is not counted.